Table 3.
Frequencies, percentages, and median survival times of risk status over the categorized age of peak height velocity separately by sex
| Male | Female | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Metabolic Syndrome †† | Metabolic Syndrome | ||||||||
| PHV Groups | Healthy | At Risk | % At Risk | Median Survival | PHV Groups | Healthy | At Risk | % At Risk | Median Survival |
| Early | 37 | 17 | 31.5% | 54.6 (43.3, 62.2) | Early | 36 | 10 | 21.7% | 65.5 (51.3, 74.9) |
| Late | 40 | 13 | 24.5% | 65.7 (56.5, 73.6) | Late | 45 | 12 | 21.1% | 60.6 (57.8, 75.1) |
|
| |||||||||
| Waist Circumference | Waist Circumference ** †† | ||||||||
|
| |||||||||
| PHV Groups | Healthy | At Risk | % At Risk | Median Survival | PHV Groups | Healthy | At Risk | % At Risk | Median Survival |
| Early | 42 | 12 | 22.2% | 54.6 (54.3, 64.2) | Early | 19 | 27 | 58.7% | 46.1 (35.4, 56.8) |
| Late | 35 | 18 | 34.0% | 58.9 (52.5, 58.5) | Late | 37 | 20 | 35.1% | 58.6 (51.3, 71.2) |
|
| |||||||||
| Blood Pressure | Blood Pressure | ||||||||
|
| |||||||||
| PHV Groups | Healthy | At Risk | % At Risk | Median Survival | PHV Groups | Healthy | At Risk | % At Risk | Median Survival |
| Early | 35 | 19 | 35.2% | 54.3 (41.6, 62.6) | Early | 40 | 6 | 13.0% | 66.5 (51.3, 71.9) |
| Late | 32 | 21 | 39.6% | 56.5 (48.2, 61.0) | Late | 42 | 15 | 26.3% | 59.4 (56.9, 74.8) |
|
| |||||||||
| Glucose †† | Glucose | ||||||||
|
| |||||||||
| PHV Groups | Healthy | At Risk | % At Risk | Median Survival | PHV Groups | Healthy | At Risk | % At Risk | Median Survival |
| Early | 33 | 21 | 38.9% | 47.1 (42.0, 58.1) | Early | 36 | 9 | 20.0% | 65.5 (47.4, 74.9) |
| Late | 36 | 16 | 30.8% | 59.9 (52.3, 68.5) | Late | 48 | 9 | 15.8% | NA (NA, NA) ‡ |
|
| |||||||||
| Triglycerides †† | Triglycerides | ||||||||
|
| |||||||||
| PHV Groups | Healthy | At Risk | % At Risk | Median Survival | PHV Groups | Healthy | At Risk | % At Risk | Median Survival |
| Early | 29 | 25 | 46.3% | 43.5 (41.6, 57.5) | Early | 31 | 15 | 32.6% | 57.3 (41.5, 74.9) |
| Late | 34 | 19 | 35.9% | 58.9 (49.6, 65.7) | Late | 38 | 20 | 34.5% | 60.0 (51.3, 63.8) |
|
| |||||||||
| HDL** †† | HDL | ||||||||
|
| |||||||||
| PHV Groups | Healthy | At Risk | % At Risk | Median Survival | PHV Groups | Healthy | At Risk | % At Risk | Median Survival |
| Early | 27 | 27 | 50.0% | 43.2 (36.6, 62.2) | Early | 25 | 21 | 45.7% | 46.1 (38.7, 65.5) |
| Late | 37 | 16 | 30.2% | 65.7 (NA, NA) ‡ | Late | 36 | 22 | 37.9% | 63.8 (42.0, 75.1) |
Pearson Chi-square test of association p-values:
*
0.05<P<0.01,
**
0.01<P<0.001,
***
P<0.001;
Log-rank test p-values:
†
0.05<P<0.01,
††
0.01<P<0.001,
†††
P<0.001;
‡
Estimates don’t exist due to heavy censoring.